SCHEMBL7957636

SCHEMBL7957636

CCOC(=O)CCCN1CCC(c2ccc(Cl)cc2F)CC1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPY1R P25929 1/20 0.47
HSD17B10 Q99714 1/20 0.46
DRD2 P14416 4/20 0.46
DRD4 P21917 2/20 0.45
DRD3 P35462 2/20 0.45
KDM4E B2RXH2 3/20 0.43
TSHR P16473 2/20 0.43
POLB P06746 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
OPRL1 P41146 2/20 0.43
ALDH1A1 P00352 2/20 0.43
MCHR1 Q99705 2/20 0.42
HTR4 Q13639 1/20 0.42
CXCR3 P49682 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7961389 0.89 NPY1R (0.50) NPY1RHSD17B10DRD2DRD4DRD3
SCHEMBL7957372 0.83 DRD2 (0.51) NPY1RDRD2DRD4DRD3KDM4E
SCHEMBL7963919 0.83 HSD17B10 (0.53) NPY1RHSD17B10DRD2DRD4DRD3
SCHEMBL7949172 0.82 DRD2 (0.61) DRD2DRD4DRD3MCHR1
SCHEMBL7949175 0.81 DRD2 (0.48) DRD2DRD4DRD3KDM4ETSHR
SCHEMBL7957657 0.81 DRD2 (0.49) NPY1RHSD17B10DRD2KDM4ETSHR
SCHEMBL7961179 0.81 DRD2 (0.47) DRD2DRD4DRD3POLBOPRL1
SCHEMBL7961467 0.80 HTR4 (0.48) NPY1RHSD17B10DRD2DRD4DRD3
SCHEMBL7961109 0.78 ALDH1A1 (0.42) NPY1RDRD2DRD4DRD3KDM4E
SCHEMBL17731192 0.78 OPRL1 (0.50) SMN1; SMN2OPRL1ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed